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Letters

Prior to rolling out the qSOFA, we would like it to be subjected to 2 challenges: (1) a comparison of its discrimination,
calibration, and clinical usefulness in various settings with
other models derived using subject matter knowledge or
based on single vital signs and (2) a prospective trial of the
effect, including patient outcomes, time burden, and costs,
of using the qSOFA in clinical practice. If the qSOFA overcomes these challenges, then we too will be as optimistic as
Seymour and colleagues.
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In Reply Both letters suggest misunderstandings about the
scientific goal of the task force, which was to explore the predictive validity of diagnostic criteria for sepsis. There is no
gold standard for sepsis, which precludes simple measures of
validity based on the presence of true positives (cases with
sepsis) and true negatives (controls without sepsis). Predictive validity permits assessment of the extent to which
potential criteria, applied in a population at risk of the
unmeasurable condition (sepsis), predict outcomes more
common in the condition.
Outcomes such as hospital mortality were chosen because sepsis is life threatening, implying that death is more
common in infected patients who have sepsis. However, mortality is not necessarily caused by sepsis. Therefore, not only
was the AUROC used but also the fold change within each decile
of baseline risk of death. This approach explores the consistency with which death occurs more frequently than expected among patients with potential criteria for sepsis. We
agree with Drs Makam and Nguyen regarding the advantages
of the NRI in the outcome prediction examples they cite, but
the situation is not analogous.
The task force did not propose the qSOFA as a standalone criterion for sepsis but rather as a prompt among clinicians of patients with infection to identify those who might
fare badly. This decision reflects consideration of more validity domains than just predictive validity. Makam and
Nguyen’s comment about SIRS and early goal-directed
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therapy is also not relevant because more than half of the
patients were outside the emergency department at the onset
of infection, and no early goal-directed therapy protocols
were uniformly adopted across all hospitals. Also, the proportion of patients with 2 or more SIRS criteria and signs of
hypoperfusion was low (<5%).1
Counter to the claims of Drs Gerdin and Baker, the task
force had no a priori hypotheses regarding which criteria would
have the greatest predictive validity. We do contend, however, that altered mentation, hypotension, and tachypnea are
biologically and clinical plausible as criteria associated with
increased odds of poor outcome. The threshold for respiratory rate was simply the cut point associated with the greatest explanatory power in the model.
The article encouraged prospective validation in other data
sets, ideally in broader settings. Gerdin and Baker suggest that
the reason for a need for validation is because the predictive
score may not calibrate well. However, calibration is not a priority for this exercise: the reasons to test externally are to understand if the fundamental relationship endures, regardless
of calibration, and then if prospective deployment can be integrated to improve care and outcomes.
A separate question is how to help clinicians manage patients in whom infection is not suspected. However, this blends
2 tasks: diagnosis of infection (beyond the remit of the task force)
and a severity of illness assessment, regardless of cause. There
are countless severity instruments, and it was not the goal to
compare the qSOFA with all possible scores. Nonetheless, it is
reassuring that the elements in the qSOFA were similar to those
of other scores such as the CURB-65,2 yet dissimilar from SIRS.
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Defining Septic Shock
To the Editor The proposed new definition of septic shock, part
of the Third International Consensus Definitions for Sepsis and
Septic Shock (Sepsis-3), requires the simultaneous presence of
hypotension and hyperlactatemia for making the diagnosis, instead of hypotension or hyperlactatemia.1 In our opinion, this
is a step backward compared with previous definitions.
First, including both hypotension and hyperlactatemia
conflicts with the pathophysiology of shock. Shock is a
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life-threatening, generalized form of acute circulatory dysfunction associated with inadequate oxygen utilization by
the cells.2 The proposed definition does not consider the
stages of shock starting with the initial hemodynamic insult
followed by early compensatory mechanisms that, when
overwhelmed, lead to progressive or refractory stages. The
new consensus definition is, in practical terms, progressive
or refractory septic shock. We understand that the intent
was to select a very high-risk population but are concerned
that, when widely applied, this definition may lead to the
underdiagnosis of shock among patients who might benefit
from early treatment.
Second, diagnosis of shock is based on a combination of clinical, hemodynamic, and biochemical signs.2 To rely only on hypotension and hyperlactatemia misses the opportunity to interpret other relevant signs of clinical hypoperfusion, such as
peripheral perfusion, which have been validated in recent years.3
Third, a recent study highlighted the relevance and drawbacks of adding lactate to the septic shock definition,4 but progressive hyperlactatemia, including lactate levels in the high
normal range, even without hypotension, is associated with
a stepwise increase in mortality.5 So a diagnosis of septic shock
in normotensive patients should not be dismissed.
Fourth, defining septic shock as hypotension and hyperlactatemia vs hypotension or hyperlactatemia can lead to very
different physiological scenarios with unpredictable consequences on patient care and outcome. The implications of the
change in definition might even be more important in low- and
middle-income settings, where awareness of and sensitivity
about an early diagnosis of shock need to be increased.
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To the Editor A panel of 19 experts conducted an extensive and
complex analysis of current literature and sepsis databases to

develop new SEPSIS-3 definitions and clinical criteria for sepsis and septic shock.1 Despite this effort, some concerns remain in regard to these definitions.
The new definition of septic shock states that “Adult patients with septic shock can be identified using the clinical criteria of hypotension requiring vasopressor therapy to maintain
mean [blood pressure] of 65 mm Hg or greater and having a serum lactate level greater than 2 mmol/L after adequate fluid
resuscitation.”1 This definition excludes a number of patients with
septic shock who are alactatemic (lactate level <2 mmol/L).
Studies show patients who remain hypotensive after administration of fluids and vasopressors with lactate levels less
than 2 mmol/L comprise as many as 50% of patients with septic shock and that mortality among these patients is as high
as 30%.2,3 Many patients may develop multisystem organ failure and die without ever having abnormal lactate levels. The
variable mortality may be related to inconsistent vasopressor
use among clinicians, sometimes before adequate volume resuscitation. In the article by Dr Shankar-Hari and colleagues,1
there was no expert consensus for serum lactate cutoff level
derived by the Delphi method, so the 2 mmol/L in the definition appears to be based on the highest crude mortality rate
in the validation cohort study. Patients without elevated lactate levels comprised 21.2% of patients in the Surviving Sepsis Campaign database, with a mortality of 30.1%. Shankar-Hari
and colleagues also provided a baseline septic shock mortality rate of 46.5% in 2001-2015, identical to the control group
mortality in the original early goal-directed therapy trial4 but
in contrast to the mortality rates of 18% to 26% observed in recent randomized clinical trials.5
The adoption of the SEPSIS-3 definition should be received
with caution when it does not address hypotensive patients with
normal lactate levels who are receiving vasopressors.
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In Reply Sepsis-3 defines septic shock as a life-threatening, generalized form of acute circulatory dysfunction (represented as
vasopressor-dependent hypotension) associated with inadequate oxygen utilization (represented as hyperlactatemia), but
with the important caveat of adequate fluid resuscitation.
This definition has strong similarities to the consensus
recommendations1 cited by Dr Hernández and colleagues. This
change in clinical criteria describing this definition will alter
the epidemiology of septic shock because of reclassification2
but should offer greater consistency, as the current incidence
varies 10-fold and mortality 4-fold.
An accepted framework was applied to evaluate complex
syndromes that incorporated content, criterion, predictive, and
construct validity principles.2 The task force considered patients with septic shock as representing a population with a
higher risk of dying than those with sepsis alone. Using the Surviving Sepsis Campaign database, crude mortality for patients with a combination of vasopressor-dependent hypotension and hyperlactatemia (>2 mmol/L) after fluids was
42.3%. This compares with 30.1% for patients with hypotension after fluids without hyperlactatemia and 25.7% for hyperlactatemia after fluids without hypotension; these differences persisted after risk adjustment. Importantly, mortality
in the latter 2 groups, which perhaps represent a state of “preshock” rather than “early shock,” was similar to that for patients without hyperlactatemia or vasopressor-dependent hypotension (25.0%).
Hernández and colleagues also raise concerns about the
availability of lactate measurement in low- and middleincome settings. We too proposed clinical assessment of the
peripheral circulation as an alternative to detect other signs
of shock,3 although such a tool must be validated and readily
reproducible.
In response to Dr Jaehne and colleagues, several factors
explain the lower mortality in trials evaluating early goaldirected therapy. Multiple exclusion criteria were operant; patients could be enrolled with hyperlactatemia (>4 mmol/L), irrespective of fluid resuscitation, many of whom respond
quickly to fluid therapy or could have fluid-refractory hypotension, and only 16% of enrolled cases had the more lifethreatening combination of hypotension and hyperlactatemia. The mortality data we derived using the Surviving Sepsis
Campaign database were confirmed in 2 additional data sets3
and in 12 004 critical care patients in England.4
Although patients without both cardiovascular dysfunction and elevated lactate levels would not meet the new definition of septic shock, we would expect a hypotensive alactatemic patient (suggested by Jaehne and colleagues), a
normotensive hyperlactatemic patient, or a normotensive alactatemic patient with other clinical signs of unwellness (suggested by Hernández and colleagues) to receive prompt, appropriate management. Caring for a sick patient should not be
delayed simply because they do not meet specific criteria—this
is just as true for the old definitions as for the new.
We do not agree that the updated septic shock definition
will worsen patient outcomes or endanger patient care. The
redefinition of a syndrome aims to provide an updated illness concept. We contend that the new definition, offering
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clearly articulated clinical criteria, will provide a stronger platform on which to build research, education, and quality improvement studies by harmonizing the multiple septic shock
case definitions currently in use.2 The framework, which emphasizes reliability and at least 1 form of validity, is a step forward from a simple consensus statement.
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Definitions for Sepsis and Septic Shock
To the Editor Dr Singer and colleagues1 reevaluated and updated the definitions of sepsis and septic shock using literature reviews, Delphi surveys of experts, and studies of several large databases. Despite some improvements, such as
easier-to-use terms (ie, sepsis rather than severe sepsis) and
development of the quick Sequential Organ Failure Assessment (qSOFA) score, a rapid bedside score without blood tests,
we have several concerns.
First, the current definitions have been successfully used
for more than 20 years. Before changing them, new definitions should be shown to be superior to the old ones. Although the methodology purportedly found the best definition, a comparison of the old vs the new definitions could have
demonstrated which was superior for different patient groups.
Second, we disagree that the systemic inflammatory response syndrome (SIRS) is unhelpful. SIRS describes a similar
clinical response for infected (septic) or noninfected patients. The term helps physicians not to refer to noninfected
patients as “septic.” More importantly, noninfected patients
with 3 or 4 SIRS criteria as opposed to 1 or 2 criteria subsequently develop severe sepsis or septic shock more frequently.2
In the original sepsis definition,3 SIRS was used to describe the
“systemic response to an infection” and severe sepsis to describe “sepsis associated with organ dysfunction, hypoperfusion or hypotension.” Rangel-Frausto and colleagues4 found
that mortality rates were 16% (not low) for SIRS and 20% for
severe sepsis.
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